Boardroom Media (CEO News)
At CEO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Los Angeles based CEO’ operating in the Health Diagnostics space. If you think a CEO’ is missing from this list, feel free to contact our editor on [email protected]
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Daniel Rotman
Founder & CEO of PrettyLitter
Harvard University’s Center for Public Leadership Fellow. Founder and CEO of PrettyLitter.
Follow Daniel Rotman:
About PrettyLitter: PrettyLitter’s lightweight litter monitors feline health by changing colors when it detects potential issues through your cat’s urine.
Paul Grand
CEO of MedTech Innovator
Follow Paul Grand:
About MedTech Innovator: MedTech Innovator is the largest lifescience accelerator in the world for medical device, digital health, and diagnostic companies
Richard Adcock
Chief Executive Officer of ImmunityBio
In January 2021, Richard (Rich) Adcock was named Chief Executive Officer of ImmunityBio. He was the former CEO of NantKwest and has been in healthcare leadership positions for for 30 years. He is known for his experience in developing cultures centered on quick, strategic innovation. He is a Six Sigma Master Black Belt, ensuring that such initiatives are complemented by strong quality systems across the organization. Adcock formerly served as CEO of Verity Health, where he oversaw a successful reorganization process. He started his career in 1992 as a co-founder and Vice President of Research and Development for Micro Medical Systems, where he helped pioneer the development of early Cardiology Electronic Medical Records. Following the company’s purchase by GE Healthcare in 1999, Adcock acquired prominent responsibilities in healthcare innovation. He eventually received an MBA in Healthcare Management and joined Sanford Health, where he was President and later Chief Innovation Officer.
Follow Richard Adcock:
About ImmunityBio, NantKwest: ImmunityBio is an offshoot of Soon-Shiong’s NantWorks conglomerate, developing molecular-level cell-based treatments for diseases.
Kyle Michelson
Founder & CEO of Getlabs
Kyle Michelson is the Founder and CEO of Getlabs. He previously founded Streamup, a live video streaming platform backed by Y Combinator, and studied at the University of Southern California and London School of Economics.
Follow Kyle Michelson:
About Getlabs: Getlabs is the nationwide leader for at-home diagnostic collections. Patients can book a nearby phlebotomist to draw their labs for Labcorp and Quest. Healthcare organizations and providers can dispatch medical specialists to their patients and collect labs, vitals, biometrics, and more.
Stella Sarraf
Chief Executive Officer, Founder & Director of Amydis, Inc.
Dr. Sarraf founded Amydis in 2013 after seeing a clinical need for diagnostics that can enable early detection of neurodegenerative diseases. She brings a blend of large pharmaceutical operational expertise, venture investment background and entrepreneurship to Amydis. Dr. Sarraf is viewed as a visionary with a deep understanding of “cradle to grave” and the necessary components to achieve success from product concept through to commercialization. Previously, she spent 10 years in Venture Capital at Foresite Capital Management and Prospect Venture Partners, both growth capital healthcare funds with over $1B dollars in assets under management. Some of the successful investments and exits by Foresite with Dr. Sarraf’s involvement included Wavetec Vision (sold to Alcon in 2014), Ambit Biosciences (acquired by Daiichi Sankyo in 2014 for $410M) and Auspex Pharmaceuticals (sold to Teva for $3.5B in 2015). At Prospect, she performed scientific, regulatory and commercial diligence on more than 400 investment opportunities from companies in therapeutic and diagnostic areas including the neurological and cognitive disorder space. Earlier in her career, Dr. Sarraf worked at Merck Research Laboratories in Rahway, New Jersey as a senior research chemist responsible for creating the chemical synthesis of a novel drug for translation from the bench to production scale.
Follow Stella Sarraf:
About Amydis, Inc., Scientific Consulting, Spinogenix, Spinogenix: A pharmaceutical company focused on developing innovative chemistry to detect diseases that involve the presence of amyloid proteins.
Robert L. Antin
President and Chief Executive Officer of VCA Antech
Robert L. Antin, one of our founders, has served as our Chief Executive Officer, President and Chairman since our inception in 1986. From September 1983 to 1985, Mr. Antin was President, Chief Executive Officer, a director and co-founder of AlternaCare Corp., a publicly held company that owned, operated and developed freestanding out-patient surgical centers. From July 1978 until September 1983, Mr. Antin was an officer of American Medical International, Inc., an owner and operator of health care facilities. Mr. Antin received his MBA with a certification in hospital and health administration from Cornell University.
Follow Robert L. Antin:
About : VCA Antech is the leading provider of pet health care services in the country with a nationwide clinical laboratory system.
Ursula Hessenflow
Founder & CEO of MyLabBox
Ursula Hessenflow-Cruz is the Co-Founder at myLAB Box.
Follow Ursula Hessenflow:
About Incubatrix, MyLabBox, YTM: MyLabBox is a home-based lab company specializing in STD testing.
Lora Lvanova
Founder & CEO of MyLabBox
Lora Lvanova is Founder at myLAB.
Follow Lora Lvanova:
About MyLabBox, ScareLA: MyLabBox is a home-based lab company specializing in STD testing.
John Bracaglia
Co-Founder and CEO of Marvin
John Bracaglia is the Co-Founder and Chief Executive Officer at Marvin.
Follow John Bracaglia:
About Marvin: Marvin is a virtual care platform that provides teletherapy and behavioral health services to healthcare workers.
Ravi Verma
CEO and Founder of Spectral Platforms
Ravi Verma is the CEO and Founder of Spectral Platforms. Ravi grew up in India and went to school at the Indian Institute of Technology, Kharagpur, where he got a Bachelor’s degree in Metallurgy in 1990. After that, he moved to Virginia Tech, where he got a Master’s degree in Materials Science in 1992, and a Ph.D. in 1994. He did a Post Doctoral stint with Prof. Herve Marand of Virginia Tech, and Dr. Benjamin Hsiao of DuPont Central Research (now at SUNY, Stony Brook). In 1996, he moved to Pasadena, CA, for another Post Doctoral stint with Prof. Julia Kornfield of CalTech (Division of Chemistry and Chemical Eng). In 1999, Ravi took up a job at a local optics/MEMS startup. In 2001, he moved to Tanner Research, where he was given the freedom to pursue a wide range of projects. In 2010, he left Tanner Research to start Spectral Platforms. Ravi is determined to see it through to success.
Follow Ravi Verma:
About Spectral Platforms: Spectral Platforms develops tools for rapid diagnosis of infectious diseases in clinical samples.
Michel Kohanim
CEO of Universal Devices
Michel Kohanim is the CTO at Universal Devices.
Follow Michel Kohanim:
About IPSO Alliance, Universal Devices: UDI Manufactures low cost automation and energy management products sold throughout North America.
Stephanie Hsieh
President & CEO of Meditope Biosciences
Follow Stephanie Hsieh:
About BIOCOM, Meditope Biosciences: Meditope Biosciences is a biotechnology company focused on developing antibody-based cancer therapeutics.
Bob Terbrueggen
President & CEO of DxTerity
Bob is the Founder and CEO of DxTerity, a patient-centric genomics company using real-world, longitudinal RNA data to better understand immune-mediated disease. With “from home” access to patients in autoimmune disease and cancer, DxTerity is improving clinical study efficiency while providing a more complete picture of immune response. Bob has over 15 years of experience in the development of revolutionary genomic technologies and products. Bob started out his career at Clinical Micro Sensors, later bought out by Motorola Life Sciences, as the Director of R&D where he oversaw the development of the world’s first bio-electronic DNA detection platform, the e-Sensor. Bob also helped start NanoBiomics to develop genomic tests for the diagnosis and prognosis of cancer that was acquired by the Molecular Profiling Institute before starting DxTerity.
Follow Bob Terbrueggen:
About DxTerity: DxTerity focuses on simplifying genomic testing, facilitating quantitative analysis of genomic bio-markers.
Martin Burns
CEO of Bruin Biometrics
Follow Martin Burns:
About Bruin Biometrics: A pioneer in biometric-sensor based medical devices; committed to earlier diagnosis and targeted intervention for chronic conditions
Jeff Greiner
Chief Executive Officer and Founder of Valencia Technologies
Jeff Greiner serves as the Chief Executive Officer and Founder at Valencia Technologies.
Follow Jeff Greiner:
About Valencia Technologies: Valencia Technologies creates, develops, manufacture, and sell a coin-sized electroceutical to treat hypertension.
Steven Reilly
Co-Founder, CEO of Mednition
Steven Reilly is a Co-Founder and CEO at Mednition Inc.
Follow Steven Reilly:
About Mednition: Mednition offers a machine learning-powered decision support solution for hospitals.
Brian Kannard
CEO of Flotherm
Brian Kannard currently works as the CEO for Flotherm.
Follow Brian Kannard:
About Flotherm: Flotherm develops a thermal compression device that maintains normothermia in a timely manner.
